- Open Access
LPS and Taxol Activate Lyn Kinase Autophosphorylation in Lpsn, but Not in Lpsd, Macrophages
© Molecular Medicine 1995
- Published: 1 May 1995
The anti-tumor agent, Taxol, has been shown in murine macrophages to stimulate tumor necrosis factor (TNF), modulate TNF receptors, induce a large panel of immediate-early genes, and induce protein tyrosine phosphorylation indistinguishably from LPS. These data, coupled with the finding that lipid A antagonists block Taxol-induced stimulation, support the hypothesis that these two structurally unrelated compounds activate a common, receptor-associated signaling apparatus. A very early event in LPS signaling of human monocytes is activation of lyn kinase activity. We therefore sought to evaluate the activation of lyn kinase by LPS and Taxol in LPS-responsive (Lpsn) and LPS-hyporesponsive (Lpsd) macrophages.
Materials and Methods
C3H/OuJ (Lpsn) and C3H/HeJ (Lpsd) macrophages were stimulated by LPS or Taxol. Cell lysates were subjected to immunoprecipitation with anti-lyn antibody, gel electrophoresis, and in vitro kinase assays. Autoradiography and Phosphor-Imager analysis were carried out to detect incorporation of 32P into lyn protein.
Within seconds of stimulation, LPS and Taxol induce in Lpsn macrophages a depression of autophosphorylation, followed within minutes by autophosphorylation of both p53 and p56 lyn species. Lpsd macrophages respond to LPS and Taxol with the initial decrease in activity, but fail to respond to LPS with autophosphorylation, and respond only to a limited extent upon Taxol stimulation. Tyrosine phosphatase inhibitors exerted inhibitory effects on LPS stimulation of lyn autophosphorylation.
Decreased lyn kinase activity within seconds and autophosphorylation within minutes of LPS or Taxol stimulation in Lpsn macrophages strongly supports the hypothesis that LPS and Taxol share a common signaling pathway. The finding that C3H/HeJ macrophages respond to LPS and Taxol with a normal depression of lyn activity, but fail to autophosphorylate lyn normally in response to LPS or Taxol, suggests that the Lpsd defect is distal to LPS-receptor interaction. Finally, the inhibitory effect of tyrosine phosphatase inhibitors on LPS-induced lyn autophosphorylation suggests that tyrosine phosphatase(s) may participate in the regulation of lyn kinase activity.
The chemotherapeutic diterpene, Taxol (paclitaxel), originally isolated from the bark of the Pacific yew Tαxus brevifolia, is now produced commercially by biochemical semisynthesis from related taxanes. Taxol has been shown to be clinically effective in 30% of ovarian cancer patients (1) and 25% of metastatic breast cancer patients (2). Though the main mechanism of Taxol’s chemotherapeutic activity is known to be inhibition of cell proliferation by stabilization of α/β tubulin depolymerization (3), recent studies have shown that Taxol has other intracellular effects that may contribute to its efficacy, particularly in macrophages. In murine macrophages, Taxol has been shown to mimic the activity of gram-negative bacterial endotoxin. Both lipopolysaccharide (LPS), the most toxic fraction of endotoxin, and Taxol induce TNF secretion (4) and the rapid involution of TNF receptors (4), and stimulate indistinguishable patterns of protein-tyrosine phosphorylation and immediate-early gene expression (5–7). Moreover, like LPS, Taxol provides a second signal to interferon-γ-primed macrophages to induce tumoricidal activity in vitro (8). Although LPS and Taxol are structurally unrelated, induction of early inflammatory response genes and tyrosine phosphorylation induced by Taxol can be blocked by antagonists that are structurally related to LPS (7). The response of murine macrophages to Taxol has been linked to the gene that controls LPS responsiveness (Lpsn) (4). Thus, the LPS-mimetic effects of Taxol are only observed in macrophages derived from LPS-responsive (Lpsn) mouse strains, and not in the LPS-hyporesponsive (Lpsd) C3H/HeJ strain (9). Taken collectively, the data suggest that Taxol and LPS share a common receptor and/or signal transducing elements.
An early signaling event known to occur within minutes in human macrophages in response to LPS is the CD14-associated activation of lyn kinase (10). To assess the possibility that lyn kinase is a common signaling molecule in LPS- and Taxol-induced effects, we compared LPS and Taxol for the ability to activate lyn kinase in both LPS-responsive Lpsn and LPS-hyporesponsive Lpsd murine macrophages.
Macrophage Culture and Reagents
Five- to six-week-old C3H/OuJ (Lpsn) or C3H/HeJ (Lpsd) mice (Jackson Laboratory, Bar Harbor, ME, U.S.A.) were used as the source of macrophages for all studies. Mice were housed in laminar flow hoods and fed autoclaved mouse chow and acidified water ad libitum until use. Thiogly-collate-elicited, peritoneal exudate macrophages were cultured in RPMI 1640 containing 2% fetal calf serum (Hyclone, Logan, UT, U.S.A.) at 20–30 × 106 cells per well in 100-mm culture plates (Falcon Plastics, Oxnard, CA, U.S.A.) and incubated at 37°C and 6% CO2 overnight, as described in detail elsewhere (11). After 20 h incubation, nonadherent cells were removed by washing with fresh medium. Cells were then incubated with medium only or with medium containing the indicated concentrations of phenol/water-extracted Escherichia coli K235 LPS (12) or Taxol (Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, U.S.A.) for the indicated time course. Taxol was stored before use as a 20 mM solution in DMSO at −70°C. Macrophage cultures were maintained at 37°C with 6% CO2 during experimental treatment. At the indicated times, media was aspirated and cells were lysed on ice in 500 µl ice-cold TNE buffer composed of 50 mM Tris Cl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% NP-40 (Fluka Chemical Corp, Ronkonkoma, NY), 0.1% DOC (Sigma Chemical Co., St. Louis, MO, U.S.A.), and 0.1% Tween 20. TNE lysis buffer was adjusted to the indicated final concentrations with the following protease inhibitors: 10 µg/ml aprotinin (Boehringer-Mannheim, Indianapolis, IN, U.S.A.), 10 µg/ml leupeptin (Boehringer-Mannheim), 5 mM NaF (Sigma), 4 mM PMSF (Sigma), 400 mM TLPCK (Sigma), and 4 mM sodium orthovanadate (Sigma). Macrophages were pretreated for 10 min with the tyrosine phosphatase inhibitor, phenylarsine oxide (PAO, Sigma), at a final concentration of 10 µM.
Kinase Assay on Cell Lysates
The in vitro kinase assay was performed essentially as described elsewhere (13). Cells were scraped vigorously from the plates with sterile cell scrapers to ensure quantitative isolation and preservation of protein components. Lysates were vortexed after sitting on ice for 10 min, were transferred to 1.5-ml screw cap tubes and centrifuged at 12,000 × g for 3 min to sediment insoluble cell fractions (pellets). For the kinase assay, lysates were immunoprecipitated at 4°C with optimized amounts of polyclonal rabbit anti-lyn antibody overnight on a serological rotator, followed by incubation with 100 µl per tube of Pansorbin Staphylococcus aureus cells (Cal-biochem, San Diego, CA, U.S.A.) for 4–6 hr. Control immunoprecipitates were prepared using affinity purified rabbit anti-mouse IgG (Cappel/OrganonTeknika, Durham, NC). Lysates were also submitted to Western blot analysis for detection of relative amounts of lyn protein in each sample. To measure the ability of the isolated lyn kinase protein to autophosphorylate as measured by incorporation of 32P, lyn immunoprecipitates were first washed once each with low-salt TNE buffer containing 150 mM NaCl and, high-salt TNE buffer containing 1 M NaCl, and low-salt TNE buffer again, prior to resuspension of the Pansorbin cells in TPK buffer (20 mM MOPS, pH 7.0, and 5 mM MnCl2). A master mix of 20 µl TPK buffer, 2.5 µl 100 µM ATP (Sigma), and 2.5 µl ATP-γ 32P (10–25 mCi/mmol, ICN, Costa Mesa, CA, U.S.A.) per sample was prepared, and 25 µl of the mix was added to each pellet of Pansorbin cells. Samples were shaken vigorously in an Eppendorf thermomixer at 25°C for 10 min, prior to stopping the incorporation reaction with the addition of 25 µl 4 X protein loading buffer (20 ml glycerol, 4 g SDS, 25 ml 0.5 M Tris HCl containing 0.4% SDS [pH 6.8], 3.1 g dithiothreitol, 1 mg bromphenol blue, H2O to 50 ml).
Electrophoresis by SDS PAGE and Quantitation by Autoradiography
Proteins were eluted from the Pansorbin in 4 X loading buffer at room temperature for 30 min. Samples were vortexed vigorously and boiled for 5 min prior to centrifugation at 12,000 × g in a microfuge for 3 min to sediment the Staphylococci. Samples of 50 µl each were loaded onto 9% SDS PAGE gels with 4% stacking gels and run at 45 V at constant current overnight. Bands were tightened with brief electrophoresis at 200 V. Gels were fixed and unincorporated label was eluted by soaking the gel in 2 changes for 1 hr each of a fixative composed of methanol:glacial acetic acid:water in the ratio of 3:1:6. Bands were visualized by 4-hr exposure of the dried gels to Kodak XAR5 film and label incorporation was quantified by Phosphorlmager technology essentially as described elsewhere (11). Briefly, after measurement of each band by Phosphorlmager analysis, the relative level of lyn autophosphorylation for each treatment was normalized to the level of autophosphorylation in medium-treated cells. Nonspecific Phosphorlmager background signal due to nonspecific incorporation of 32P from control samples immunoprecipitated with polyclonal rabbit anti-mouse antibody averaged 7.6% of the specific signal detected in medium-treated cells for all experiments (n = 17). For multiple experiments, the geometric mean of the relative autophosphorylation level demonstrated by identical treatment groups is presented.
Western Blot Analysis
Equivalent volumes of cell lysates or pellets were dissolved in 4 X protein loading buffer and 10–15 µl samples electrophoresed through 10% SDS PAGE, pH 8.35 with 4% stacking gels, pH 6.8 in a BioRad mini-Protean II at 100 V at constant current. Western transfers of proteins to Immobilon (Amersham Corp., Arlington Heights, IL, U.S.A.) membranes were prepared by electrophoretic transfer at 100 V for 1 hr at 4°C in Tris-Glycine-Methanol transfer buffer. Membranes were stained by incubation on a serological rotator in 1 µg/ml of the appropriate primary antibody diluted in TBS + 0.1% Tween 20 for 40 min at room temperature after blocking for 45 min or storage in blocking buffer containing 1 % gelatin and 5% nonfat milk in TBS. After blocking and between primary and secondary antibody treatments, membranes were washed for optimized times in changes of TBS + 0.1% Tween 20. BiRad Affinity purified horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit IgG antibody (BioRad) was diluted 1:2500 in TBS + 0.1% Tween 20 and used for secondary antibody incubations of 50 min at room temperature. Bands on the Western transfer were visualized by means of ECL (Amersham) chemiluminescent reagents and autoradiography on Kodak XAR5 film as described elsewhere (7).
LPS and Taxol Activation of Lyn Autophosphorylation
Effect of LPS and Taxol on lyn Activity in C3H/HeJ (Lpsd) Macrophages
Effects of Phenylarsine Oxide (PAO) on lyn Activity
Taxol has been found to serve as an LPS mimetic for patterns of protein tyrosine phosphorylation, gene induction, TNF release, TNF receptor recycling, the development of tumoricidal effects in murine macrophages (4–8), and NFκB translocation (P.-Y. Perera, unpublished observations). These commonalities imply that part or all of the signaling mechanisms for LPS and Taxol is shared. Lyn is a member of the src family of nontransmembrane protein tyrosine kinases. Src protein kinases are constitutively associated with cellular membranes as the result of the first 16 residues of the protein in combination with co-valent, cotranslational myristylation of glycine residue 2 (14). Lyn can also be further modified by post-translational palmitylation that occurs on cysteine residue 3 (14). Like other Src family members, lyn is thought to be maintained in an enzymatically repressed (inactive) conformation that is dependent upon the association of a phosphotyrosine residue in the carboxyterminal portion of the molecule with the enzyme’s own aminoterminal SH2 domain (15). Thus, in this model, enzymatic activity is associated with a conformational change that exposes the active site of the enzyme, perhaps mediated by the action of a phosphatase that cleaves the carboxyterminal phosphate. Activation of lyn kinase is also associated with the autophosphorylation of a second tyrosine residue within the catalytic domain. CD14, a nonsignaling receptor for LPS, and its catalytic serum binding protein, LBP (16,17), have been shown to be associated transiently with lyn kinase after LPS stimulation. Since LPS hyporesponsiveness exhibited by C3H/HeJ mice has been attributed to a single gene defect (reviewed in Ref. 9), associated with membrane components (18), and genetically linked to Taxol unresponsiveness (4), we reasoned that analysis of lyn activation in LPS-defective macrophages might provide important insights into the nature of the Lpsd defect.
LPS-responsive C3H/OuJ macrophages responded to Taxol with activation of lyn autophosphorylation that is essentially identical to the LPS response, with the exception of timing (Fig. 2). This observation supports previous data that Taxol shares at least some of the LPS-response receptor signaling molecules (7). The average delay of the peak of LPS-induced lyn autophosphorylation activity may imply that Taxol interacts more efficiently with a molecule that is slightly upstream in the LPS signaling pathway. LPS-hyporesponsive C3H/HeJ macrophages did not respond to LPS with increased activation of lyn, although the initial depression in activity appeared to be C3H/OuJ-like. This common depression may be due to a specific, LPS-induced intracellular phosphatase that dephosphorylates the autophosphorylation site of lyn, thus rendering it less activated. Alternatively, inhibition of lyn activity could be related to the activation of a specific tyrosine kinase that selectively phosphorylates the carboxyterminal site, thus favoring the repressive conformation. Lack of a subsequent peak of lyn activity suggests that the defect in C3H/HeJ macrophages is expressed downstream of CD 14 and/or other receptor-LPS interactions that lead to the initial depression in lyn activity and prior to the induction of lyn autophosphorylation that, in turn, may lead to the activation of downstream Ras, Raf, and MAP kinases (19). The suboptimal autophosphorylation response of Taxol-treated C3H/HeJ macrophages following the initial depression of activity may imply that Taxol is capable of eliciting signaling pathways that are independent of and in addition to those shared with LPS. Coupled with the observation that Taxol-induced autophosphorylation precedes that induced by LPS, this finding provides a second example of subtle cell signaling differences between Taxol and LPS stimulation of macrophages.
Signal transduction by a variety of different types of surface receptors requires the proper balance between the activities of protein tyrosine kinases and protein tyrosine phosphatases (20). PAO has been shown to be an effective inhibitor of protein tyrosine phosphatases and thereby may shift this balance towards the accumulation of protein tyrosine phosphorylation. It is thus possible that PAO treatment of Lpsn macrophages causes lyn to undergo autophosphorylation at the catalytic site in the cell, thereby reducing the capacity of the enzyme to autophosphorylate in immune complex kinase assays. Alternatively, PAO may inhibit the action of an LPS-induced tyrosine phosphatase that acts normally to remove the carboxyterminal phosphate, thus rendering the active site of the enzyme exposed. It is possible that the failure of LPS to increase lyn activity in C3H/HeJ macrophages may represent a phosphatase dysregulation that is analogous to the effect of PAO pretreatment of C3H/OuJ macrophages.
In summary, lyn kinase is a common signaling element in response of macrophages to both Taxol and LPS. Modulation of lyn activity is initiated normally in C3H/HeJ macrophages, yet these cells fail to increase the level of lyn autophosphorylation, in contrast to C3H/OuJ macrophages. Taxol- and LPS-induced lyn activation is potentially under positive control by tyrosine phosphatase(s) since tyrosine phosphatase inhibitors exerted negative effects on LPS-induced lyn activity. Further search for intracellular proteins that physically interact with Taxol are likely to identify proteins shared in the LPS signal transduction mechanism.
This work was supported by National Institutes of Health Grant AI-18797 (SNV). The opinions or assertions contained within are the private views of the authors and should not be construed as official or necessarily reflecting the views of USUHS or the Department of Defense. The experiments reported herein were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, National Research Council DHEW Publication No. (NIH) 85-23. The authors are extremely thankful to Dr. Joseph Bolen for his very thoughtful discussions and critical review of this manuscript and the Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, U.S.A., for Taxol.
- (1991) Physician’s Desk Reference. Medical Economics Data, Montvale, NJ.Google Scholar
- Nightingale S. (1994) Paclitaxel approved for treatment of certain breast cancer patients. J.A.M.A. 271: 1818.View ArticlePubMedGoogle Scholar
- Rowinsky EK, Donehower RC, Jones RJ, Tucker RW. (1988) Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48: 4093–4099.PubMedGoogle Scholar
- Ding AH, Porteu F, Sanchez E, Nathan CF. (1990) Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370–372.View ArticlePubMedGoogle Scholar
- Carboni JM, Singh C, Tepper MA. (1993) Taxol and lipopolysaccharide activation of a murine macrophage cell line and induction of similar tyrosine phosphoproteins. Monogr. Natl. Cancer Inst. 15: 95–101.Google Scholar
- Manthey CL, Brandes ME, Perera P-Y, Vogel SN. (1992) Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J. Immunol. 149: 2459–2465.PubMedGoogle Scholar
- Manthey CL, Qureshi N, Stütz PL, Vogel SN. (1993) Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J. Exp. Med. 178: 695–701.View ArticlePubMedGoogle Scholar
- Manthey CL, Perera P-Y, Salkowski CA, Vogel SN. (1994) Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol 152: 825–831.PubMedGoogle Scholar
- Vogel SN. (1992) The Lps gene: Insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation. In: Beutler B (ed). Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press, New York, pp. 485–513.Google Scholar
- Stefanova I, Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak ID. (1993) Lipopolysaccharide induces activation of CD14-associates protein tyrosine kinase p53/56lyn. J. Biol. Chem. 268: 20725–20728.PubMedGoogle Scholar
- Henricson BE, Manthey CL, Perera P-Y, Hamilton TA, Vogel SN. (1993) Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61: 2325–2333.PubMedPubMed CentralGoogle Scholar
- Mclntire FC, Sievert HW, Barlow GH, Finley RA, Lee WY. (1967) Chemical physical and biological properties of a lipopolysaccharide from Escherichia coli K235. Biochemistry 6: 2363–2372.View ArticleGoogle Scholar
- Burkhardt AL, Bolen JB. (1993) Immune-complex assays for tyrosine protein kinases. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. eds. Current Protocols in Immunology. Greene Publishing Associates and Wiley-Interscience, New York, pp. 11.4.1–11.4.8.Google Scholar
- Resh M. (1994) Myristylation and palmitylation of src family members: The fats of the matter. Cell 76: 411–413.View ArticlePubMedGoogle Scholar
- Cooper JA, Howell B. (1993) The when and how of src regulation. Cell 73: 1051–1054.View ArticlePubMedGoogle Scholar
- Hailman E, Lichenstein HS, Wurfel MM, et al. (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD 14. J. Exp. Med. 179: 269–277.View ArticlePubMedGoogle Scholar
- Weinstein SL, June CH, DeFranco AL. (1993) Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD 14. J. Immunol. 151: 3829–3838.PubMedGoogle Scholar
- Jacobavits A, Sharon N, Zan-Bar I. (1982) Acquisition of mitogenic responsiveness by non-responding lymphocytes upon insertion of appropriate membrane components. J. Exp. Med. 156: 1274–1279.View ArticleGoogle Scholar
- Geppert TD, Whitehurst CE, Thompson P, Beutler B. (1994) Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the Ras/Raf-1/MEK/MAPK pathway. Mol. Med. 1: 93–103.PubMedPubMed CentralGoogle Scholar
- Girault J-A. (1994) Protein kinases and phosphatases. Neurotransmissions 10: 1–6.Google Scholar